GlassScriptPhysician profile
Peter A Ingraldi
NPI 1154492874
$4,407.71
in general payments reported to CMS, 2019-2025
39 companies · $968 in 2025
The $968 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $768 · 2020: $379 · 2021: $139 · 2022: $534 · 2023: $795 · 2024: $823 · 2025: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,567 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,566.79 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $903.54 | 2019-2025 | Collagenase Santyl, Grafix Pl, Grafix |
| Organogenesis INC. | $629.35 | 2019-2025 | Affinity, Apligraf, Puraply Wound Matrix |
| Solventum Corporation | $479.61 | 2024-2025 | Promogran Prisma, Activ.A.C., 3m Cavilon |
| Kerecis Limited | $281.86 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Hydrofera LLC | $189.33 | 2023-2025 | Hydrofera Blue, Cutimed Sorbion |
| Aroa Biosurgery Incorporated | $150.00 | 2023 | |
| Abiomed | $145.83 | 2019 | |
| Pfizer INC. | $144.94 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $126.35 | 2019 | |
| Davol INC. | $125.77 | 2023-2024 | Phasix Mesh |
| Janssen Pharmaceuticals, INC | $122.18 | 2020 | |
| Medtronic, INC. | $96.60 | 2023-2024 | Signia |
| Paratek Pharmaceuticals, INC. | $95.51 | 2022 | |
| Integra Lifesciences Corporation | $90.80 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Csl Behring | $75.96 | 2020-2023 | Kcentra |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $75.13 | 2022-2025 | Harmonic, Ethicon, Vistaseal |
| Kci USA, INC. | $67.12 | 2022-2023 | Kerramax Care, Activ.A.C., 3m Cavilon |
| Inari Medical, INC. | $58.66 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Convatec INC. | $45.85 | 2022-2023 | |
| Dilon Technologies, INC. | $45.78 | 2025 | Hemoblast Bellows |
| Cardiovascular Systems INC. | $43.29 | 2019 | |
| Innocoll Pharmaceuticals Limited | $39.59 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $33.49 | 2019 | |
| Urgo Medical North America, LLC | $32.63 | 2024 | Urgoclean Ag |
| Ipsen Biopharmaceuticals, INC | $31.77 | 2020 | |
| Alexion Pharmaceuticals, INC. | $28.71 | 2021-2022 | |
| Next Science LLC | $25.67 | 2023-2024 | Xperience, Surgx, Blastx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.63 | 2019 | |
| Tei Biosciences INC | $23.91 | 2019 | |
| Boston Scientific Corporation | $21.25 | 2024 | Spyglass Discover |
| Celgene Corporation | $19.96 | 2019 | |
| Tactile Systems Technology INC | $19.04 | 2024 | Flexitouch Plus, Entre Plus |
| Bioventus LLC | $18.84 | 2022 | |
| Acell, INC. | $17.31 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.46 | 2019 | |
| Teleflex LLC | $16.28 | 2023 | Quikclot |
| Heron Therapeutics, INC. | $15.83 | 2022 | |
| Portola Pharmaceuticals, LLC | $14.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ingraldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.